Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Aethlon Medical (AEMD) Accumulated Depreciation & Amortization (2016 - 2024)

Historic Accumulated Depreciation & Amortization for Aethlon Medical (AEMD) over the last 13 years, with Q1 2024 value amounting to $990550.0.

  • Aethlon Medical's Accumulated Depreciation & Amortization rose 74314.33% to $990550.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $990550.0, marking a year-over-year increase of 74314.33%. This contributed to the annual value of $990550.0 for FY2024, which is 74314.33% up from last year.
  • Aethlon Medical's Accumulated Depreciation & Amortization amounted to $990550.0 in Q1 2024, which was up 74314.33% from -$154017.0 recorded in Q1 2023.
  • Aethlon Medical's Accumulated Depreciation & Amortization's 5-year high stood at $990550.0 during Q1 2024, with a 5-year trough of -$154017.0 in Q1 2023.
  • Over the past 5 years, Aethlon Medical's median Accumulated Depreciation & Amortization value was $385545.0 (recorded in 2020), while the average stood at $403837.2.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first crashed by 14138.31% in 2023, then skyrocketed by 74314.33% in 2024.
  • Over the past 5 years, Aethlon Medical's Accumulated Depreciation & Amortization (Quarter) stood at $385545.0 in 2020, then increased by 10.22% to $424934.0 in 2021, then fell by 12.42% to $372174.0 in 2022, then crashed by 141.38% to -$154017.0 in 2023, then soared by 743.14% to $990550.0 in 2024.
  • Its Accumulated Depreciation & Amortization was $990550.0 in Q1 2024, compared to -$154017.0 in Q1 2023 and $372174.0 in Q1 2022.